Web Results

Do We Still Need Pioglitazone for the Treatment of Type 2 Diabetes ...

care.diabetesjournals.org/content/36/Supplement_2/S155

Type 2 diabetes mellitus (T2DM) is a serious, chronic, and progressive disease that is rapidly increasing in prevalence. The disease now affects >10% of adults ...

Pioglitazone: a review of its use in type 2 diabetes mellitus. - NCBI

www.ncbi.nlm.nih.gov/pubmed/16398569

Drugs. 2006;66(1):85-109. Pioglitazone: a review of its use in type 2 diabetes mellitus. Waugh J(1), Keating GM, Plosker GL, Easthope S, Robinson DM.

Pioglitazone for type 2 diabetes mellitus | Cochrane

www.cochrane.org/CD006060/ENDOC_pioglitazone-for-type-2-diabetes-mellitus

Oct 18, 2006 ... Pioglitazone for type 2 diabetes mellitus. Diseases of the heart and blood vessels account for approximately 70% of all mortality in people with ...

Pioglitazone - a review of its use in type 2 diabetes mellitus (PDF ...

www.researchgate.net/publication/7372351_Pioglitazone_-_a_review_of_its_use_in_type_2_diabetes_mellitus

In clinical trials in patients with type 2 diabetes mellitus, pioglitazone as monotherapy, or in combination with metformin, repaglinide, insulin or a sulphonylurea, ...

FDA approves first generic Actos to treat type 2 diabetes

www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm315951.htm

Aug 17, 2012 ... The U.S. Food and Drug Administration today approved the first generic version of Actos (pioglitazone hydrochloride) tablets. Along with diet ...

Pioglitazone Versus Metformin in Type 2 Diabetes - Full Text View ...

clinicaltrials.gov/ct2/show/NCT00815399

Dec 29, 2008 ... Type 2 diabetes is an epidemic. Its long-term consequences translate into enormous human suffering and economic costs; however, much of ...

Pioglitazone for type 2 diabetes mellitus (Review)

onlinelibrary.wiley.com/doi/10.1002/14651858.CD006060.pub2/pdf

Richter B, Bandeira-Echtler E, Bergerhoff K, Clar C, Ebrahim SH. Pioglitazone for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2006, ...

Benefit/Risk Profile Remains Positive for Pioglitazone as an ...

www.takeda.com/news/2015/20151216_7251.html

Dec 16, 2015 ... Benefit/Risk Profile Remains Positive for Pioglitazone as an Important Treatment Option for Type 2 Diabetes. Takeda Comments on Letters to ...

The use of pioglitazone and the risk of bladder cancer in people with ...

www.bmj.com/content/344/bmj.e3645

May 31, 2012 ... Objective To determine if the use of pioglitazone is associated with an increased risk of incident bladder cancer in people with type 2 diabetes.

Spotlight on Pioglitazone in Type 2 Diabetes Mellitus1 - Springer

link.springer.com/content/pdf/10.2165/00024677-200605030-00006.pdf

patients with type 2 diabetes mellitus, pioglitazone as monotherapy, or in combination with metformin, repaglinide, insulin, or a sulfonylurea, induced both long- ...

Answer
Find Health Information on Healthline
Find Info About:
Healthline is the leading provider of health information.
More Info

Pioglitazone for type 2 diabetes mellitus. - NCBI

www.ncbi.nlm.nih.gov

Oct 18, 2006 ... Pioglitazone for type 2 diabetes mellitus. Richter B(1), Bandeira-Echtler E, Bergerhoff K, Clar C, Ebrahim SH. Author information:

pioglitazone, Actos: Side Effects,Dosing, and Generic - MedicineNet

www.medicinenet.com

Aug 4, 2015 ... Pioglitazone (Actos) is a drug prescribed for the treatment of type 2 diabetes. Side effects, drug interactions, dosing, and pregnancy and ...

Actos - Type 2 Diabetes Drug, Uses & Side Effects - Drugwatch.com

www.drugwatch.com

Actos (pioglitazone) is a Type 2 diabetes medication that regulates blood sugar levels in the body. Learn about its uses, interactions and side effects.